December 12, 2024 20:42 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal
Bharat Biotech develops oral cholera vaccine Hillchol

Bharat Biotech develops oral cholera vaccine Hillchol

Aug 28, 2024, at 06:46 am

Hyderabad:  Bharat Biotech International Limited (BBIL) has announced the launch of Hillchol (BBV131), a new single-strain Oral Cholera Vaccine (OCV) developed under a license from Hilleman Laboratories, which is funded by Merck, USA, and Wellcome Trust, UK. The vaccine aims to combat cholera.

Latest Headlines
Bharat Biotech develops oral cholera vaccine Hillchol Wed, Aug 28 2024